mibefradil has been researched along with Long QT Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
| Barhanin, J; Chouabe, C; Drici, MD; Lazdunski, M; Romey, G | 1 |
| Gläser, S; Kleber, FX; Opitz, C; Steinbach, M; Wruck, U | 1 |
3 other study(ies) available for mibefradil and Long QT Syndrome
| Article | Year |
|---|---|
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.
Topics: Animals; Benzimidazoles; Bepridil; Calcium Channel Blockers; Cloning, Molecular; COS Cells; Heart; Ion Channel Gating; Long QT Syndrome; Membrane Potentials; Mibefradil; Potassium Channels; Tetrahydronaphthalenes; Transfection; Verapamil | 1998 |
Torsades de pointes caused by Mibefradil.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Female; Humans; Hypertension; Long QT Syndrome; Mibefradil; Tachycardia, Ventricular; Torsades de Pointes | 2001 |